Profile data is unavailable for this security.
About the company
Shaanxi Meibang Pharmaceutical Group Co Ltd is a company mainly engaged in the research and development (R&D), production and sales of pesticide preparations. The Company's products mainly include fungicides and pesticides. The fungicides include 80% dimethylmorpholine water dispersible granules, 27% chunleimycin bromonitrile wettable powder, 72% pyrazole ether ester combined water dispersible granules, 22% chunleimycin chlorobromoisocyanuric acid wettable powder, etc. The insecticides include 21% abamectin benzoate fenitrile suspension, 22% thiamethoxam beta cypermethrin suspension, 45% biphenyl hydrazide ethiconazole suspension, 20% fenitrile bifenthrin suspension, etc.
- Revenue in CNY (TTM)666.41m
- Net income in CNY32.72m
- Incorporated1998
- Employees939.00
- LocationShaanxi Meibang Pharmaceutical Group Co LtdHigh-Tech Industrial Development ZonePucheng County,XI'AN 715500ChinaCHN
- Phone+86 2 986183766
- Fax+86 2 989820615
- Websitehttp://www.meibang.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang Hisun Biomaterials Co Ltd | 802.46m | 46.30m | 1.98bn | 383.00 | 42.77 | 1.33 | -- | 2.47 | 0.2284 | 0.2284 | 3.96 | 7.34 | 0.4005 | 5.24 | 19.52 | 2,095,207.00 | 2.31 | -- | 2.84 | -- | 12.78 | -- | 5.77 | -- | 2.10 | -- | 0.2166 | -- | 24.43 | -- | -7.41 | -- | -- | -- |
| Shandong Cynda Chemical Co Ltd | 2.42bn | -156.07m | 2.00bn | 2.18k | -- | 1.01 | -- | 0.8267 | -0.3718 | -0.3718 | 5.62 | 4.58 | 0.6828 | 2.67 | 6.93 | 1,112,224.00 | -4.34 | 6.37 | -7.21 | 9.16 | 8.47 | 23.74 | -6.36 | 7.48 | 0.8941 | -- | 0.2825 | 35.64 | -20.58 | 8.70 | -125.68 | -- | -10.16 | -- |
| Shaanxi Meibang Pharmaceuticl Grp Co Ltd | 666.41m | 32.72m | 2.05bn | 939.00 | 62.53 | 1.77 | -- | 3.07 | 0.2421 | 0.2421 | 4.93 | 8.57 | 0.4276 | 1.62 | 2.31 | 709,697.40 | 2.10 | 8.61 | 2.54 | 12.57 | 29.91 | 36.78 | 4.91 | 13.69 | 2.31 | -- | 0.0596 | 15.66 | -22.85 | 9.77 | -60.33 | -0.6051 | 42.34 | -- |
| Argus Shanghai Textile Chemicals Co Ltd | 799.55m | 51.24m | 2.13bn | 517.00 | 40.88 | 1.76 | -- | 2.66 | 0.2717 | 0.2717 | 4.17 | 6.30 | 0.4777 | 1.46 | 3.10 | 1,546,523.00 | 2.92 | 4.20 | 3.94 | 5.28 | 29.08 | 28.80 | 6.11 | 7.48 | 1.05 | 11.67 | 0.1413 | 35.06 | 0.7462 | -3.83 | 6.18 | -19.44 | 13.51 | -15.40 |
| Suli Co Ltd | 1.89bn | -5.18m | 2.15bn | 1.58k | -- | 0.8675 | -- | 1.14 | -0.0269 | -0.0269 | 10.43 | 13.76 | 0.349 | 4.61 | 6.12 | 1,197,981.00 | -0.1977 | 6.90 | -0.2914 | 10.61 | 11.52 | 23.64 | -0.5665 | 12.22 | 1.70 | -- | 0.3572 | 32.42 | -37.84 | 3.54 | -93.63 | -42.23 | 36.47 | -39.16 |
| Tianjin Jiuri New Materials Co Ltd | 1.23bn | -96.14m | 2.19bn | 1.25k | -- | 0.8315 | -- | 1.77 | -0.892 | -0.892 | 11.43 | 24.26 | 0.3052 | 3.32 | 6.06 | 984,837.00 | -2.57 | 2.90 | -3.45 | 3.70 | 7.87 | 23.03 | -8.42 | 7.83 | 1.53 | -- | 0.2712 | 40.89 | -12.47 | 4.20 | -321.70 | -- | 28.23 | -- |
Data as of May 24 2024. Currency figures normalised to Shaanxi Meibang Pharmaceutical Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
2.29%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Gfund Management Co., Ltd.as of 31 Dec 2023 | 424.20k | 1.26% |
| Western Leadbank Fund Management Co., Ltdas of 31 Dec 2023 | 293.80k | 0.87% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 17.90k | 0.05% |
| Guolian Fund Management Co. Ltd.as of 31 Dec 2023 | 16.00k | 0.05% |
| Fortune & Royal Asset Management Co., Ltd.as of 31 Dec 2023 | 8.00k | 0.02% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2023 | 7.90k | 0.02% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 2.12k | 0.01% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 2.12k | 0.01% |
| Bank of Communications Schroder Fund Management Co., Ltd.as of 30 Jun 2023 | 1.40k | 0.00% |
| Lion Fund Management Co., Ltd.as of 31 Dec 2023 | 1.27k | 0.00% |
More ▼
Data from 31 Dec 2023 - 16 May 2024Source: FactSet Research Systems Inc.
